logo.png
Arch Biopartners Provides Update on Phase II Trial for LSALT Peptide
August 05, 2021 06:30 ET | Arch Biopartners
TORONTO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating...
devpro logo.png
COPD Foundation and DevPro Biopharma Join Forces to Develop Treatments for People with COPD and Related Lung Conditions
March 23, 2021 06:00 ET | DevPro Biopharm
Miami, FL, and Basking Ridge, NJ , March 23, 2021 (GLOBE NEWSWIRE) -- The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma LLC, a clinical research and development company,...
Arch Scientist Publishes Data on the Pre-Clinical Efficacy of AB569 in Killing of Drug Resistant Bacteria
February 21, 2020 08:00 ET | Arch Biopartners
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9328b8b7-9f45-4361-915c-3a569b3716a0 TORONTO, Feb. 21, 2020 (GLOBE NEWSWIRE) --  Arch...
logo.png
Arch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569, Designed to Target Chronic Infection and Antibiotic Resistance
March 27, 2018 09:08 ET | Arch Biopartners
TORONTO, March 27, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB:ACHFF), announced today that the U.S. Patent and Trademark Office has issued U.S....
Ingen ATMC logo
Topout Provides Global-Leading Oxygen Delivery Systems
July 03, 2013 10:15 ET | Ingen Technologies, Inc.
-Ingen Makes Head-way in the UK and Europe- --Topout Oxygeneering Ltd: Leading Provider, High Altitude Oxygen Delivery System—Ingen's Oxyview Technology: Oxyview Climbs Mt. Everest:...